Inquilinus limosus Bacteremia in Lung Transplant Recipient after SARS-CoV-2 Infection.
COVID-19
France
Inquilinus limosus
Revillet H
Roux A
SARS-CoV-2
Suggested citation for this article: Farfour E
Vallée A
Vasse M. Inquilinus limosus bacteremia in lung transplant recipient after SARS-CoV-2 infection. Emerg Infect Dis. 2023 Mar [date cited]. https://doi.org/10.3201/eid2903.221564
Zrounba M
bacteremia
bacteria
cystic fibrosis
graft dysfunction
lung transplant recipient
respiratory infections
viruses
Journal
Emerging infectious diseases
ISSN: 1080-6059
Titre abrégé: Emerg Infect Dis
Pays: United States
ID NLM: 9508155
Informations de publication
Date de publication:
03 2023
03 2023
Historique:
entrez:
24
2
2023
pubmed:
25
2
2023
medline:
3
3
2023
Statut:
ppublish
Résumé
Inquilinus limosus is an environmental bacterium associated with respiratory tract colonization in cystic fibrosis patients. We report a case of I. limosus bacteremia in a patient in France who received a lung transplant and experienced chronic graft dysfunction and SARS-CoV-2 infection. This case suggests I. limosus displays virulence factors associated with invasion.
Identifiants
pubmed: 36823767
doi: 10.3201/eid2903.221564
pmc: PMC9973706
doi:
Types de publication
Case Reports
Letter
Langues
eng
Sous-ensembles de citation
IM
Pagination
642-644Références
J Heart Lung Transplant. 2015 Sep;34(9):1220-3
pubmed: 26267744
J Clin Microbiol. 2009 Nov;47(11):3435-8
pubmed: 19741077
Emerg Infect Dis. 2008 Jun;14(6):993-5
pubmed: 18507928
Diagn Microbiol Infect Dis. 2006 Nov;56(3):317-20
pubmed: 16854551
J Clin Microbiol. 1999 Dec;37(12):3851-5
pubmed: 10565895
Gen Thorac Cardiovasc Surg. 2020 Aug;68(8):833-840
pubmed: 31848904
Sci Rep. 2016 Nov 29;6:37955
pubmed: 27897253
J Heart Lung Transplant. 2021 Aug;40(8):733-744
pubmed: 34120840
J Cyst Fibros. 2016 Nov;15(6):769-775
pubmed: 26996269
J Med Microbiol. 2006 Oct;55(Pt 10):1425-1433
pubmed: 17005793